CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
CTSA 临床试验基础设施
基本信息
- 批准号:8365224
- 负责人:
- 金额:$ 164.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject represents an estimate of the percentage of the CTSA funding that is
being utilized for a broad area of research (AIDS research, pediatric research, or
clinical trials). The Total Cost listed is only an estimate of the amount of CTSA
infrastructure going towards this area of research, not direct funding provided by
the NCRR grant to the subproject or subproject staff.
The overall goal of this CTSA program is to create an integrated, efficient, and proactive academic home to promote, facilitate, and transform clinical and translational research at Northwestern University (NU) and its affiliated clinical institutions. The program includes participation by six NU schools and all four of its affiliated hospitals. The focal point of this application is the new Northwestern University Clinical and Translational Sciences (NUCATS) Institute, a physical and intellectual home for its leaders, member faculty, and research trainees. The major principle driving this program of teaching, research development, and infrastructure is that an integrated and focused research organization can propel the translation of research findings into mproved patient care and population health more rapidly and effectively than the decentralized approaches to clinical and translational research that now exist in most academic institutions. The NU CTSA application has 4 goals: 1. Provide new, broad-based, and coordinated leadership to accelerate translation of ideas into health-care solutions within the Northwestern University community and beyond by systematically studying and promoting multidisciplinary research interactions in the context of new research teams and, in so doing, to gain fundamental insights into the process of clinical/translational collaboration 2. Create and support a new and expanded set of research and training resources (tools) that will support new discoveries, new technology development, and translational team-based research 3. Educate and encourage a broad range of scientists.and health care providers to study and solve important health problems in a team-based environment at the interfaces between fundamental science, clinical medicine, and the community 4. Evaluate the impact of the new tools and new collaborations that we have developed in order to continuously improve our outcomes. The faculty leaders chosen to direct the Institute and its functional components have the experience, authority, and committed time to administer the new home for clinical and translational research. The Program benefits from an outstanding research environment and tremendous institutional support.
该子项目是对CTSA供资的百分比的估计,
用于广泛的研究领域(艾滋病研究,儿科研究,或
临床试验)。 列出的总成本仅为CTSA金额的估算
基础设施走向这一领域的研究,而不是直接提供资金,
向子项目或子项目工作人员提供NCRR补助金。
该CTSA计划的总体目标是创建一个综合,高效和积极的学术家园,以促进,促进和转变西北大学(NU)及其附属临床机构的临床和转化研究。该计划包括六所NU学校及其所有四家附属医院的参与。该应用程序的焦点是新的西北大学临床和转化科学(NUCATS)研究所,其领导人,成员教师和研究学员的物理和智力家园。推动这一教学,研究开发和基础设施计划的主要原则是,一个综合的和有重点的研究组织可以推动研究成果转化为改善病人护理和人口健康更迅速,更有效地比分散的方法,临床和转化研究,现在存在于大多数学术机构。NU CTSA应用程序有4个目标:1。提供新的,基础广泛的,协调的领导,以加快思想转化为医疗保健解决方案在西北大学社区内外通过系统地研究和促进多学科研究的新的研究团队的背景下相互作用,并在这样做,以获得临床/翻译合作过程的基本见解2。创建和支持一套新的和扩展的研究和培训资源(工具),以支持新发现,新技术开发和基于翻译团队的研究。教育和鼓励广泛的科学家和医疗保健提供者在基础科学,临床医学和社区之间的界面上以团队为基础的环境中研究和解决重要的健康问题。评估我们开发的新工具和新合作的影响,以不断改善我们的成果。选择指导研究所及其职能部门的教师领导人有经验,权威和承诺的时间来管理临床和转化研究的新家。该计划受益于出色的研究环境和巨大的机构支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip Greenland其他文献
Philip Greenland的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip Greenland', 18)}}的其他基金
Continuation of the NuMoM2b Heart Health Study
NuMoM2b 心脏健康研究的延续
- 批准号:
10905863 - 财政年份:2023
- 资助金额:
$ 164.87万 - 项目类别:
Continuation of the NuMoM2b Heart Health Study
NuMoM2b 心脏健康研究的延续
- 批准号:
10676495 - 财政年份:2020
- 资助金额:
$ 164.87万 - 项目类别:
Stress and Racial Disparities in Preeclampsia - Clues from DNA Methylomic Profiling
先兆子痫的压力和种族差异 - DNA 甲基组学分析的线索
- 批准号:
10418273 - 财政年份:2020
- 资助金额:
$ 164.87万 - 项目类别:
Continuation of the NuMoM2b Heart Health Study
NuMoM2b 心脏健康研究的延续
- 批准号:
10657212 - 财政年份:2020
- 资助金额:
$ 164.87万 - 项目类别:
Continuation of the NuMoM2b Heart Health Study
NuMoM2b 心脏健康研究的延续
- 批准号:
10200499 - 财政年份:2020
- 资助金额:
$ 164.87万 - 项目类别:
Continuation of the NuMoM2b Heart Health Study
NuMoM2b 心脏健康研究的延续
- 批准号:
10288873 - 财政年份:2020
- 资助金额:
$ 164.87万 - 项目类别:
Continuation of the NuMoM2b Heart Health Study
NuMoM2b 心脏健康研究的延续
- 批准号:
10556399 - 财政年份:2020
- 资助金额:
$ 164.87万 - 项目类别:
Continuation of the NuMoM2b Heart Health Study
NuMoM2b 心脏健康研究的延续
- 批准号:
10338143 - 财政年份:2020
- 资助金额:
$ 164.87万 - 项目类别:
MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)
多学科临床和转化科学 (MCTS) 计划 (UL1)
- 批准号:
8365223 - 财政年份:2011
- 资助金额:
$ 164.87万 - 项目类别:
相似海外基金
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 164.87万 - 项目类别:
Fellowship
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
RareKids-CAN:儿科罕见病临床试验和治疗网络
- 批准号:
495575 - 财政年份:2023
- 资助金额:
$ 164.87万 - 项目类别:
Operating Grants
Unbiased estimation in hierarchical models for Clinical trials
临床试验分层模型中的无偏估计
- 批准号:
2884930 - 财政年份:2023
- 资助金额:
$ 164.87万 - 项目类别:
Studentship
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 164.87万 - 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10855627 - 财政年份:2023
- 资助金额:
$ 164.87万 - 项目类别:
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES
CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动
- 批准号:
10895949 - 财政年份:2023
- 资助金额:
$ 164.87万 - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
- 批准号:
10891325 - 财政年份:2023
- 资助金额:
$ 164.87万 - 项目类别:
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
- 批准号:
10761602 - 财政年份:2023
- 资助金额:
$ 164.87万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 164.87万 - 项目类别:














{{item.name}}会员




